(Bloomberg) -- H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug ...
The two drugs will account for nearly two-thirds of Lundbeck's revenues in that year, predicted the company's president and CEO Charl ... has agreed to buy Longboard Pharmaceuticals for $2.6 ...
Lind, president and CEO of Longboard in the announcement ... Longboard was founded in 2020 by Arena Pharmaceuticals, another San Diego biopharma company that was later acquired by Pfizer.